Faculty

Institution

Unit

Venue

Shanna Babalonis

Associate Professor

University of Kentucky

Affiliations

College of Medicine

Behavioral Science

Center on Drug and Alcohol Research

Shanna Babalonis is currently serving as a Behavioral Science Associate Professor at University of Kentucky.

Honors

Create free account to unlock more features

Experiences

Create free account to unlock more features

Education

Create free account to unlock more features

Shanna Babalonis

University of Kentucky

Associate Professor

You can click a keyword to filter the displayed items

pharmacology addiction psychiatry psychopharmacology public health substance abuse neuropharmacology pharmacotherapy health sciences addiction medicine drug treatment addiction treatment cannabis use women's health clinical pharmacology endocrinology neuropsychopharmacology pharmacological research pharmacokinetics abuse liability opioid withdrawal clinical trials addiction biology respiratory medicine opioid use disorder oral cannabidiol mental health clinical research medicinal research substance use tobacco use drug safety psychotropic medication opioid epidemic alcohol dependence experimental pharmacology secondary metabolites cardiovascular effects oral dronabinol placebo-controlled study healthy pre-menopausal women frequent marijuana smokers addictive behaviors clinical chemistry neuroethics pain research pain medicine attention disorders criminal justice natural product research therapeutic efficacy behavioral health case studies underserved populations treatment effects dopamine preclinical drug evaluation substance addiction correctional practice opioid overdose behavioral medicine drug tests drug assessment psychiatric genetics driver performance evidence-based practice phytopharmacology psychoactive substance use smoked cannabis randomized placebo-controlled trial cannabis use disorder oral tramadol opioid dependent humans safety concerns widespread availability legal status sustainable development cannabis legalization

Notable Scholarly Works

Notable Federal Grants

Collaborators

A Dose-Ranging Study of the Physiological and Self-Reported Effects of Repeated, Rapid Infusion of Remifentanil in People With Opioid Use Disorder and Physical Dependence on Fentanyl. Psychopharmacology (2024)

Joshua A LileThomas P ShellenbergShanna BabalonisKevin W HattonLon R HaysAbner O RayapatiWilliam W StoopsMichael J Wesley

opioid use disordermedicinepain managementpharmacologypsychopharmacologydrug treatmentpharmacotherapyneuropharmacologyaddiction medicinephysical dependencepsychiatryaddictionaddiction treatmentrapid infusionclinical pharmacologydose-ranging study

Minor Cannabinoid Profile of Unregulated Cannabidiol Products. Cannabis and Cannabinoid Research (2024)

Erin JohnsonMichael KilgorePaul NuzzoShanna Babalonis

medicinal chemistrycannabis usepsychoactive substance useneuropharmacologyaddictionminor cannabinoid profilesubstance use disorderssecondary metabolitesneuropsychopharmacologyunregulated cannabidiol productsaddiction medicinepsychiatrysubstance usepharmacological researchpharmacologypsychopharmacologyphytopharmacologydrug discoverynatural product researchneuroscience

Pharmacokinetics of Oral Cannabinoid Δ8-Tetrahydrocannabivarin and Its Main Metabolites in Healthy Participants. Pharmaceuticals (2024)

Cristina SempioJorge Campos-PalominoJelena KlawitterErica N. PetersLaura MacNairMehdi HaghdoostMarcel O. Bonn-MillerAmy HarrisonShanna BabalonisUwe ChristiansJost Klawitter

clinical evidencetoxicologyinfectious diseaseshivchemical compositionselective toxicitysecondary metabolitesdermatologymain metabolitestherapeutic targetsbioactive compoundspharmacological researchpharmacognosyimmunologysubstance abuseenzyme inhibitionhealthy participantsmedicinal researchmulti-scale studiestobacco control

Residual Next-Day Effects of Alprazolam on Psychomotor Performance and Simulated Driving in Healthy Normal Adults.. Experimental and Clinical Psychopharmacology (2024)

Stevie C RoszkowskiShanna BabalonisMarion A CoePaul A NuzzoMichelle R LofwallLaura C FanucchiSharon L Walsh

alcohol (drug)psychopharmacologydriver behaviorpsychomotor performanceresidual next-day effectsphysical activitypsychologyhealthy normal adultspsychiatryaddictionexperimental pharmacologytraffic psychologyexperimental psychologyhuman performancebehavioral sciences

A Two-Phase, Dose-Ranging, Placebo-Controlled Study of the Safety and Preliminary Test of Acute Effects of Oral Δ 8 -Tetrahydrocannabivarin in Healthy Participants. Cannabis and Cannabinoid Research (2023)

Erica N. PetersLaura MacNairAmy HarrisonMatthew T. FeldnerGraham M.L. EglitShanna BabalonisCynthia TurcotteMarcel O. Bonn-Miller

drug safetypharmacologyplacebo-controlled studypreliminary testacute effectsdrug testsclinical researchhealthy participantscannabis use

Cannabis Effects on Driving Performance: Clinical Considerations. Medical Cannabis and Cannabinoids (2023)

Brianna CostalesShanna L. BabalonisJoshua D. BrownAmie J. Goodin

medicinepharmacologycannabis effectspsychiatryclinical considerationshuman performancedriver performance

Cannabidiol (Cbd) Product Contamination: Quantitative Analysis of Δ9-Tetrahydrocannabinol (Δ9-Thc) Concentrations Found in Commercially Available Cbd Products. Drug and Alcohol Dependence (2022)

Erin JohnsonMichael KilgoreShanna Babalonis

public healthmedicinal chemistrypharmacologyquantitative analysisproduct contamination

Cannabinoid Poisoning-Related Emergency Department Visits and Inpatient Hospitalizations in Kentucky, 2017 to 2019. Substance Use & Misuse (2022)

Stevie C. BritchSharon L. WalshRachel Vickers-SmithShanna BabalonisSvetla Slavova

public healthsubstance abusemedicineemergency medicinesubstance useinpatient hospitalizationstoxicologyrespiratory medicine

Label Accuracy of Unregulated Cannabidiol (Cbd) Products: Measured Concentration vs. Label Claim. Journal of Cannabis Research (2022)

Erin JohnsonMichael KilgoreShanna Babalonis

label accuracyunregulated cannabidiolhealth scienceslabel claim

Recent Increase in Methamphetamine Use in a Cohort of Rural People Who Use Drugs: Further Evidence for the Emergence of Twin Epidemics. Frontiers in Psychiatry (2022)

Jennifer R. HavensHannah K. KnudsenJustin C. StricklandApril M. YoungShanna BabalonisMichelle R. LofwallSharon L. Walsh

public healthsubstance abusefurther evidenceopioid epidemicepidemiologycriminologypsychiatryaddictionmethamphetamine useunderserved populationsrural peoplepsychiatric epidemiologyrural healthtwin epidemics

1
2
3
4
5
10 / page

Shanna Babalonis

Associate Professor

University of Kentucky

Affiliations

College of Medicine

Behavioral Science

Center on Drug and Alcohol Research

Shanna Babalonis is currently serving as a Behavioral Science Associate Professor at University of Kentucky.

Honors

Create free account to unlock more features

Experiences

Create free account to unlock more features

Education

Create free account to unlock more features

Shanna Babalonis

University of Kentucky

Associate Professor

You can click a keyword to filter the displayed items

Notable Scholarly Works

Notable Federal Grants

Collaborators

Joshua A LileThomas P ShellenbergShanna BabalonisKevin W HattonLon R HaysAbner O RayapatiWilliam W StoopsMichael J Wesley

Minor Cannabinoid Profile of Unregulated Cannabidiol Products. Cannabis and Cannabinoid Research (2024)

Erin JohnsonMichael KilgorePaul NuzzoShanna Babalonis

Pharmacokinetics of Oral Cannabinoid Δ8-Tetrahydrocannabivarin and Its Main Metabolites in Healthy Participants. Pharmaceuticals (2024)

Cristina SempioJorge Campos-PalominoJelena KlawitterErica N. PetersLaura MacNairMehdi HaghdoostMarcel O. Bonn-MillerAmy HarrisonShanna BabalonisUwe ChristiansJost Klawitter

Residual Next-Day Effects of Alprazolam on Psychomotor Performance and Simulated Driving in Healthy Normal Adults.. Experimental and Clinical Psychopharmacology (2024)

Stevie C RoszkowskiShanna BabalonisMarion A CoePaul A NuzzoMichelle R LofwallLaura C FanucchiSharon L Walsh

Erica N. PetersLaura MacNairAmy HarrisonMatthew T. FeldnerGraham M.L. EglitShanna BabalonisCynthia TurcotteMarcel O. Bonn-Miller

drug safetypharmacologyplacebo-controlled studypreliminary testacute effectsdrug testsclinical researchhealthy participantscannabis use

Cannabis Effects on Driving Performance: Clinical Considerations. Medical Cannabis and Cannabinoids (2023)

Brianna CostalesShanna L. BabalonisJoshua D. BrownAmie J. Goodin

medicinepharmacologycannabis effectspsychiatryclinical considerationshuman performancedriver performance

Cannabidiol (Cbd) Product Contamination: Quantitative Analysis of Δ9-Tetrahydrocannabinol (Δ9-Thc) Concentrations Found in Commercially Available Cbd Products. Drug and Alcohol Dependence (2022)

Erin JohnsonMichael KilgoreShanna Babalonis

public healthmedicinal chemistrypharmacologyquantitative analysisproduct contamination

Cannabinoid Poisoning-Related Emergency Department Visits and Inpatient Hospitalizations in Kentucky, 2017 to 2019. Substance Use & Misuse (2022)

Stevie C. BritchSharon L. WalshRachel Vickers-SmithShanna BabalonisSvetla Slavova

public healthsubstance abusemedicineemergency medicinesubstance useinpatient hospitalizationstoxicologyrespiratory medicine

Label Accuracy of Unregulated Cannabidiol (Cbd) Products: Measured Concentration vs. Label Claim. Journal of Cannabis Research (2022)

Erin JohnsonMichael KilgoreShanna Babalonis

label accuracyunregulated cannabidiolhealth scienceslabel claim

Recent Increase in Methamphetamine Use in a Cohort of Rural People Who Use Drugs: Further Evidence for the Emergence of Twin Epidemics. Frontiers in Psychiatry (2022)

Jennifer R. HavensHannah K. KnudsenJustin C. StricklandApril M. YoungShanna BabalonisMichelle R. LofwallSharon L. Walsh

1
2
3
4
5
10 / page

Similar Faculty Members

Michelle Lofwall

Institution

University of Kentucky

health policy

harm reduction

William Stoops

Institution

University of Kentucky

pharmacology

addiction

Joshua Lile

Institution

University of Kentucky

psychiatry

drug choice

Peter Martin

Institution

Vanderbilt University

psychiatry

magnetic resonance spectroscopy

Lara Ray

Institution

University of California, Los Angeles

psychoactive substance use

substance use disorder

William Dewey

Institution

Virginia Commonwealth University

neuropathic pain

pharmacology

Mark Greenwald

Institution

Wayne State University

psychiatry

psychology

William E. Fantegrossi

Institution

University of Arkansas for Medical Sciences

pharmacological research

addictive behavior

Christina Meade

Institution

Duke University

psychology

addictive behavior

John Rotrosen, M.D

Institution

New York University

psychiatry

biological psychiatry

Similar Faculty Members

Michelle Lofwall

Institution

University of Kentucky

health policy

harm reduction

William Stoops

Institution

University of Kentucky

pharmacology

addiction

Joshua Lile

Institution

University of Kentucky

psychiatry

drug choice

Peter Martin

Institution

Vanderbilt University

psychiatry

magnetic resonance spectroscopy

Lara Ray

Institution

University of California, Los Angeles

psychoactive substance use

substance use disorder

William Dewey

Institution

Virginia Commonwealth University

neuropathic pain

pharmacology

Mark Greenwald

Institution

Wayne State University

psychiatry

psychology

William E. Fantegrossi

Institution

University of Arkansas for Medical Sciences

pharmacological research

addictive behavior

Christina Meade

Institution

Duke University

psychology

addictive behavior

John Rotrosen, M.D

Institution

New York University

psychiatry

biological psychiatry